Our Story

Genecast Biotechnology is a leading oncology molecular diagnostics and testing company in China, provides precision diagnostics products and services to assist patients to make decisions in cancer therapy selection, evaluate or improve treatment options and provide cancer early screening for high-risk populations. It is dedicated to serve as the most professional and trusted partner for hospitals and patients, and is one of the few oncology molecular diagnostics and testing companies in China to provide one-stop solutions to hospitals.  

Leadership
01——07
DU Bo
Founder & Chief Executive Officer
ZHANG Henghui
Founder & Chief Medical Officer
MA Guosheng
Founder & Executive Vice President
ZUO Honggang
Chief Financial Officer
HE Ji
Chief Information Officer
CHEN Weizhi
Chief Scientific Officer
WANG Jerry
Vice President, Corporate Development
Qualification
Inspection institute qualification
Corporate certificate
<
SCCL EQA Certificate
<
SCCL EQA Certificate
<
SCCL EQA Certificate
<
Jiangsu Certification for EQA
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
High-tech Enterprise.
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
Jiangsu Certification for EQA
<
Jiangsu Certification for EQA
<
Jiangsu Certification for EQA
<
SCCL EQA Certificate
<
NCCL EQA Certificate
<
JIANGSU CERTIFICATION FOR EQA
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
CAP Accredited
<
High-tech Enterprise.
<
Zhongguancun High-tech Enterprise.
<
NGS Qualification
<
ARMS Qualification
<
High-tech Enterprise.
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
SCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
History

2014/11

Genecast Biotechnology was established in the PRC.

2016/01

We launched Genecast Comprehensive.

2017/06

We launched Genecast PD-L1.

2017/07

We launched Genecast Lung and Genecast CRC.

2017/12

We were awarded National High-tech Enterprise Certificate.

2018/04

Wuxi Genecast Laboratory obtained the Practice License of Medical Institution.

2018/09

We launched MammaPrint® licensed from Agendia in China.

2018/10

Wuxi laboratory was certified by U.S. College of American Pathologist.

2018/12

Taizhou manufacturing facility obtained the YY/T0287- 2017 idt ISO 13485:2016 certification.

2019/09

Wuxi laboratory was certified as a PCR laboratory to carry out “tumor-related genetic testing activities (with conventional ARMS method and NGS method)”.

2019/09

Awarded 2019 EY Fudan China Most Promising Enterprises Award by Ernst & Young.

2019/11

We launched Genecast Lung TILs.

2020/04

We launched Genecast RNA Fusion Focus.

2020/11

We launched Genecast MRD – Lung.

2020/11

We launched TumorX with the participation of Zhejiang University.

2021/02

We obtained our first IVD product registration certificate from NMPA for Genecast IVD – CRC.

2021/07

We launched Genecast Genius G1 and Genecast INTEGRO V1.0, both certified by NMPA.

2021/08

We launched Immunoscore® licensed from Veracyte in China.

2021/11

We launched Tissue of Origin® in China.

2022/02

We launched Genecast MRD – CRC.

2014/11

Genecast Biotechnology was established in the PRC.

2016/01

We launched Genecast Comprehensive.

2017/06

We launched Genecast PD-L1.

2017/07

We launched Genecast Lung and Genecast CRC.

2017/12

We were awarded National High-tech Enterprise Certificate.

2018/04

Wuxi Genecast Laboratory obtained the Practice License of Medical Institution.

2018/09

We launched MammaPrint® licensed from Agendia in China.

2018/10

Wuxi laboratory was certified by U.S. College of American Pathologist.

2018/12

Taizhou manufacturing facility obtained the YY/T0287- 2017 idt ISO 13485:2016 certification.

2019/09

Wuxi laboratory was certified as a PCR laboratory to carry out “tumor-related genetic testing activities (with conventional ARMS method and NGS method)”.

2019/09

Awarded 2019 EY Fudan China Most Promising Enterprises Award by Ernst & Young.

2019/11

We launched Genecast Lung TILs.

2020/04

We launched Genecast RNA Fusion Focus.

2020/11

We launched Genecast MRD – Lung.

2020/11

We launched TumorX with the participation of Zhejiang University.

2021/02

We obtained our first IVD product registration certificate from NMPA for Genecast IVD – CRC.

2021/07

We launched Genecast Genius G1 and Genecast INTEGRO V1.0, both certified by NMPA.

2021/08

We launched Immunoscore® licensed from Veracyte in China.

2021/11

We launched Tissue of Origin® in China.

2022/02

We launched Genecast MRD – CRC.

Press Releases
Careers

Genecast was established in Beijing in 2014 and is headquartered in the city of Wuxi, Jiangsu Province. With the next-generation sequencing technology and bioinformatics as the core, the company is engaged in non-invasive and precise diagnosis and diagnosis of tumors, and is committed to becoming a leader in improving the quality of life of cancer patients. With the next-generation sequencing technology and bioinformatics as the core, the company is engaged in non-invasive and precise diagnosis and diagnosis of tumors, and is committed to becoming a leader in improving the quality of life of cancer patients.

Email :zhaopin@genecast.com.cn
Job Responsibilities
  • · Quality Manager
  • · Product Manager
  • · Sales Representative
  • · Sales Assistant
  • · Medical Specialist
  • · Customer Service
Contact Us

We are committed to being improved
the leader in the quality of life of cancer patients.